Literature DB >> 27668889

MiR-139-5p is associated with inflammatory regulation through c-FOS suppression, and contributes to the progression of primary biliary cholangitis.

Tomohiro Katsumi1, Masashi Ninomiya2, Taketo Nishina1, Kei Mizuno1,3, Kyoko Tomita1,3, Hiroaki Haga1, Kazuo Okumoto1, Takafumi Saito1, Tooru Shimosegawa2, Yoshiyuki Ueno1,3.   

Abstract

Primary biliary cholangitis (PBC) is a chronic cholestatic liver disease characterized pathologically by destruction of intrahepatic bile ducts. PBC is largely classified into three subtypes based on clinical course: (i) gradually progressive, (ii) portal hypertension, and (iii) hepatic failure. Previous studies have indicated that serum levels of the pro-inflammatory cytokine TNF-α, is elevated in PBC patients with fibrosis. Although the severity of cholangitis might also be related to the PBC subtype, its etiology has been unclear. Several studies have shown that microRNAs (miRNAs) demonstrate specific expression patterns in various diseases. In the present study, we evaluated miRNA expression patterns among the PBC subtypes using comprehensive deep sequencing. We also carried out histologic examination by laser capture microdissection and investigated how the identified miRNAs were involved in PBC clinical progression using the miRNA transfection method. On average, ~11 million 32-mer short RNA reads per sample were obtained, and we found that the expression levels of 97 miRNAs differed significantly among the four groups. Heat mapping demonstrated that the miRNA profiles from hepatic failure and portal hypertension type were clustered differently from those of the gradually progressive type and controls. Furthermore, we focused on miR-139-5p, which has an adequate number of total short reads. Quantitative reverse transcription PCR showed that miR-139-5p was significantly downregulated in clinically advanced PBC. Also, examination of liver tissues demonstrated that the expression of lymphocyte-derived miR-139-5p was significantly higher in hepatocytes. In vitro, the level of TNF-α was significantly elevated in supernatant of cells with upregulation of miR-139-5p. Furthermore, c-FOS gene transcription was repressed. Thus, we have demonstrated a novel inflammation-regulatory mechanism involving TNF-α and c-FOS transcription through miR-139-5p in the NF-κB signaling pathway. We conclude that the specific miRNA miR-139-5p might be involved in the pathogenesis of PBC, especially during clinical progression.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27668889     DOI: 10.1038/labinvest.2016.95

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  47 in total

Review 1.  Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review.

Authors:  Kirsten Boonstra; Ulrich Beuers; Cyriel Y Ponsioen
Journal:  J Hepatol       Date:  2012-01-13       Impact factor: 25.083

2.  Natural history of early primary biliary cirrhosis.

Authors:  J V Metcalf; H C Mitchison; J M Palmer; D E Jones; M F Bassendine; O F James
Journal:  Lancet       Date:  1996-11-23       Impact factor: 79.321

Review 3.  AP-1 as a regulator of cell life and death.

Authors:  Eitan Shaulian; Michael Karin
Journal:  Nat Cell Biol       Date:  2002-05       Impact factor: 28.824

4.  Expression of micro-RNAs in peripheral blood mononuclear cells from primary biliary cirrhosis patients.

Authors:  Fumiko Katsushima; Atsushi Takahashi; Natsumi Sakamoto; Yukiko Kanno; Kazumichi Abe; Hiromasa Ohira
Journal:  Hepatol Res       Date:  2013-08-15       Impact factor: 4.288

5.  The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis.

Authors:  Christophe Corpechot; Fabrice Carrat; Abbas Bahr; Yves Chrétien; Renée-Eugénie Poupon; Raoul Poupon
Journal:  Gastroenterology       Date:  2005-02       Impact factor: 22.682

Review 6.  Primary biliary cirrhosis and Sjögren's syndrome: autoimmune epithelitis.

Authors:  Carlo Selmi; Pier Luigi Meroni; M Eric Gershwin
Journal:  J Autoimmun       Date:  2011-12-16       Impact factor: 7.094

7.  Concurrent autoimmune diseases in patients with autoimmune hepatitis.

Authors:  Andreas Teufel; Arndt Weinmann; George J Kahaly; Catherine Centner; Anja Piendl; Marcus Wörns; Ansgar W Lohse; Peter R Galle; Stephan Kanzler
Journal:  J Clin Gastroenterol       Date:  2010-03       Impact factor: 3.062

8.  Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases.

Authors:  Xi Chen; Yi Ba; Lijia Ma; Xing Cai; Yuan Yin; Kehui Wang; Jigang Guo; Yujing Zhang; Jiangning Chen; Xing Guo; Qibin Li; Xiaoying Li; Wenjing Wang; Yan Zhang; Jin Wang; Xueyuan Jiang; Yang Xiang; Chen Xu; Pingping Zheng; Juanbin Zhang; Ruiqiang Li; Hongjie Zhang; Xiaobin Shang; Ting Gong; Guang Ning; Jun Wang; Ke Zen; Junfeng Zhang; Chen-Yu Zhang
Journal:  Cell Res       Date:  2008-10       Impact factor: 25.617

9.  Primary structure of the human M2 mitochondrial autoantigen of primary biliary cirrhosis: dihydrolipoamide acetyltransferase.

Authors:  R L Coppel; L J McNeilage; C D Surh; J Van de Water; T W Spithill; S Whittingham; M E Gershwin
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

10.  Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants.

Authors:  Gideon M Hirschfield; Xiangdong Liu; Chun Xu; Yue Lu; Gang Xie; Yan Lu; Xiangjun Gu; Erin J Walker; Kaiyan Jing; Brian D Juran; Andrew L Mason; Robert P Myers; Kevork M Peltekian; Cameron N Ghent; Catalina Coltescu; Elizabeth J Atkinson; E Jenny Heathcote; Konstantinos N Lazaridis; Christopher I Amos; Katherine A Siminovitch
Journal:  N Engl J Med       Date:  2009-05-20       Impact factor: 91.245

View more
  8 in total

1.  Diagnostic and therapeutic potentials of microRNAs in cholangiopathies.

Authors:  Indsey Kennedy; Heather Francis; Fanyin Meng; Shannon Glaser; Gianfranco Alpini
Journal:  Liver Res       Date:  2017-04-26

Review 2.  The Roles of microRNAs in Regulating the Expression of PD-1/PD-L1 Immune Checkpoint.

Authors:  Qingshui Wang; Wei Lin; Xiaoqiong Tang; Suhuan Li; Libin Guo; Yao Lin; Hang Fai Kwok
Journal:  Int J Mol Sci       Date:  2017-11-27       Impact factor: 5.923

Review 3.  Recent Advances in Understanding Cholangiocarcinoma.

Authors:  Lindsey Kennedy; Laura Hargrove; Jennifer Demieville; Nicole Francis; Rowan Seils; Sara Villamaria; Heather Francis
Journal:  F1000Res       Date:  2017-10-09

Review 4.  Biomarkers for primary biliary cholangitis: current perspectives.

Authors:  Elias Kouroumalis; Demetrius Samonakis; Argyro Voumvouraki
Journal:  Hepat Med       Date:  2018-06-18

5.  RNA sequencing reveals changes in the microRNAome of transdifferentiating hepatic stellate cells that are conserved between human and rat.

Authors:  Laura Sabater; Luigi Locatelli; Fiona Oakley; Timothy Hardy; Jeremy French; Stuart M Robinson; Gourab Sen; D A Mann; Jelena Mann
Journal:  Sci Rep       Date:  2020-12-10       Impact factor: 4.379

Review 6.  Roles of Non-Coding RNAs in Primary Biliary Cholangitis.

Authors:  Yaqin Zhang; Ziying Jiao; Mingwei Chen; Bing Shen; Zongwen Shuai
Journal:  Front Mol Biosci       Date:  2022-07-08

7.  MicroRNA expression profile in chronic nonbacterial prostatitis revealed by next-generation small RNA sequencing.

Authors:  Li Zhang; Yi Liu; Xian-Guo Chen; Yong Zhang; Jing Chen; Zong-Yao Hao; Song Fan; Li-Gang Zhang; He-Xi Du; Chao-Zhao Liang
Journal:  Asian J Androl       Date:  2019 Jul-Aug       Impact factor: 3.285

8.  Plasma Extracellular Vesicles Enhance HIV-1 Infection of Activated CD4+ T Cells and Promote the Activation of Latently Infected J-Lat10.6 Cells via miR-139-5p Transfer.

Authors:  Isobel Okoye; Lai Xu; Olaide Oyegbami; Shima Shahbaz; Desmond Pink; Priscilla Gao; Xuejun Sun; Shokrollah Elahi
Journal:  Front Immunol       Date:  2021-06-24       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.